Search

Author/Creator Oder, Daniel

1. Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study. Issue 5 (7th February 2018)

Authors:
Arends, Maarten; Biegstraaten, Marieke; Wanner, Christoph; Sirrs, Sandra; Mehta, Atul; Elliott, Perry M; Oder, Daniel; Watkinson, Oliver T; Bichet, Daniel G; Khan, Aneal; Iwanochko, Mark; Vaz, Frédéric M; van Kuilenburg, André B P; West, Michael L; Hughes, Derralynn A; Hollak, Carla E M
Journal:
Journal of medical genetics
Issue:
Volume 55:Issue 5(2018)
Page Start:
351
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease. Issue 2 (12th July 2018)

Authors:
Liu, Dan; Oder, Daniel; Salinger, Tim; Hu, Kai; Müntze, Jonas; Weidemann, Frank; Herrmann, Sebastian; Ertl, Georg; Wanner, Christoph; Frantz, Stefan; Störk, Stefan; Nordbeck, Peter
Journal:
Open heart
Issue:
Volume 5:Issue 2(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve Stenosis. (11th November 2018)

Authors:
Salinger, Tim; Hu, Kai; Liu, Dan; Taleh, Scharoch; Herrmann, Sebastian; Oder, Daniel; Gensler, Daniel; Müntze, Jonas; Ertl, Georg; Lorenz, Kristina; Frantz, Stefan; Weidemann, Frank; Nordbeck, Peter
Other Names:
Trinkmann Frederik Guest Editor.
Journal:
Cardiology research and practice
Issue:
Volume 2018(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study. Issue 21 (May 2018)

Authors:
Oder, Daniel; Liu, Dan; Üçeyler, Nurcan; Sommer, Claudia; Hu, Kai; Salinger, Tim; Müntze, Jonas; Petritsch, Bernhard; Ertl, Georg; Wanner, Christoph; Nordbeck, Peter; Weidemann, Frank
Other Names:
Cheng. Xiwen section editor.
Journal:
Medicine
Issue:
Volume 97:Issue 21(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Letter by Oder et al Regarding Article, "Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography. (August 2018)

Authors:
Oder, Daniel; Wanner, Christoph; Nordbeck, Peter
Journal:
Circulation
Issue:
Volume 11:Number 8(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Lucerastat, an Iminosugar for Substrate Reduction Therapy: Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Fabry Disease on Enzyme Replacement. Issue 4 (28th August 2017)

Authors:
Guérard, Nicolas; Oder, Daniel; Nordbeck, Peter; Zwingelstein, Christian; Morand, Olivier; Welford, Richard W.D.; Dingemanse, Jasper; Wanner, Christoph
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 103:Issue 4(2018)
Page Start:
703
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year. Issue 5 (13th January 2019)

Authors:
Müntze, Jonas; Gensler, Daniel; Maniuc, Octavian; Liu, Dan; Cairns, Tereza; Oder, Daniel; Hu, Kai; Lorenz, Kristina; Frantz, Stefan; Wanner, Christoph; Nordbeck, Peter
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 105:Issue 5(2019)
Page Start:
1224
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗